Literature DB >> 21091716

Neurokinin-1 receptor: functional significance in the immune system in reference to selected infections and inflammation.

Steven D Douglas1, Susan E Leeman.   

Abstract

The G protein-coupled receptor (GPCR), <span class="Gene">neurokinin-1 receptor (NK1R), and its preferred ligand, substance P (SP), are reviewed in relationship to the immune system and selected infections. NK1R and SP are ubiquitous throughout the animal kingdom. This important pathway has unique functions in numerous cells and tissues. The interaction of SP with its preferred receptor, NK1R, leads to the activation of nuclear factor-kappa B (NF-κB) and proinflammatory cytokines. NK1R has two isoforms, both a full-length and a truncated form. These isoforms have different functional significances and differ in cell signaling capability. The proinflammatory signals modulated by SP are important in bacterial, viral, fungal, and parasitic diseases, as well as in immune system function. The SP-NK1R system is a major class 1, rhodopsin-like GPCR ligand-receptor interaction.
© 2010 New York Academy of Sciences.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21091716      PMCID: PMC3058850          DOI: 10.1111/j.1749-6632.2010.05826.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  125 in total

1.  Substance P antagonist (CP-96,345) inhibits HIV-1 replication in human mononuclear phagocytes.

Authors:  J P Lai; W Z Ho; G X Zhan; Y Yi; R G Collman; S D Douglas
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

Review 2.  Tachykinin-mediated modulation of the immune response.

Authors:  Kenneth L Bost
Journal:  Front Biosci       Date:  2004-09-01

3.  The proliferative and antiapoptotic effects of substance P are facilitated by formation of a beta -arrestin-dependent scaffolding complex.

Authors:  K A DeFea; Z D Vaughn; E M O'Bryan; D Nishijima; O Déry; N W Bunnett
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

Review 4.  Characterization of the gene structures, precursor processing and pharmacology of the endokinin peptides.

Authors:  Nigel M Page
Journal:  Vascul Pharmacol       Date:  2006-07-06       Impact factor: 5.773

Review 5.  The role of substance P in inflammatory disease.

Authors:  Terence M O'Connor; Joseph O'Connell; Darren I O'Brien; Triona Goode; Charles P Bredin; Fergus Shanahan
Journal:  J Cell Physiol       Date:  2004-11       Impact factor: 6.384

6.  A non-peptide substance P antagonist down-regulates SP mRNA expression in human mononuclear phagocytes.

Authors:  Jian-Ping Lai; Wen-Zhe Ho; Ji-Hong Yang; Xu Wang; Li Song; Steven D Douglas
Journal:  J Neuroimmunol       Date:  2002-07       Impact factor: 3.478

Review 7.  Neurokinin 1 receptor antagonists--current prospects.

Authors:  Giuseppe Alvaro; Romano Di Fabio
Journal:  Curr Opin Drug Discov Devel       Date:  2007-09

8.  Human lymphocytes express substance P and its receptor.

Authors:  J P Lai; S D Douglas; W Z Ho
Journal:  J Neuroimmunol       Date:  1998-06-01       Impact factor: 3.478

9.  Mutations in the extracellular amino-terminal domain of the NK2 neurokinin receptor abolish cAMP signaling but preserve intracellular calcium responses.

Authors:  Sandra Lecat; Bernard Bucher; Yves Mely; Jean-Luc Galzi
Journal:  J Biol Chem       Date:  2002-08-15       Impact factor: 5.157

10.  Effects of subchronic treatment with imipramine, zimelidine and alaproclate on regional tissue levels of substance P- and neurokinin A/neurokinin B-like immunoreactivity in the brain and spinal cord of the rat.

Authors:  E Brodin; S O Ogren; E Theodorsson-Norheim
Journal:  Neuropharmacology       Date:  1987-06       Impact factor: 5.250

View more
  62 in total

1.  Substance P and Antagonists of the Neurokinin-1 Receptor in Neuroinflammation Associated with Infectious and Neurodegenerative Diseases of the Central Nervous System.

Authors:  Alejandra N Martinez; Mario T Philipp
Journal:  J Neurol Neuromedicine       Date:  2016

Review 2.  Promising pharmacogenetic targets for treating alcohol use disorder: evidence from preclinical models.

Authors:  Jennifer A Rinker; Patrick J Mulholland
Journal:  Pharmacogenomics       Date:  2017-03-27       Impact factor: 2.533

Review 3.  Recent advances in our understanding of mast cell activation - or should it be mast cell mediator disorders?

Authors:  Theoharis C Theoharides; Irene Tsilioni; Huali Ren
Journal:  Expert Rev Clin Immunol       Date:  2019-04-22       Impact factor: 4.473

4.  Substance P and IL-33 administered together stimulate a marked secretion of IL-1β from human mast cells, inhibited by methoxyluteolin.

Authors:  Alexandra Taracanova; Irene Tsilioni; Pio Conti; Errol R Norwitz; Susan E Leeman; Theoharis C Theoharides
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-19       Impact factor: 11.205

Review 5.  Involvement of substance P and the NK-1 receptor in pancreatic cancer.

Authors:  Miguel Muñoz; Rafael Coveñas
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

6.  The Role of Substance P in Pulmonary Clearance of Bacteria in Comparative Injury Models.

Authors:  Terry Hsieh; Max H Vaickus; Thor D Stein; Bethany L Lussier; Jiyoun Kim; David M Stepien; Elizabeth R Duffy; Evan L Chiswick; Daniel G Remick
Journal:  Am J Pathol       Date:  2016-12       Impact factor: 4.307

7.  Intracellular emetic signaling cascades by which the selective neurokinin type 1 receptor (NK1R) agonist GR73632 evokes vomiting in the least shrew (Cryptotis parva).

Authors:  W Zhong; S Chebolu; N A Darmani
Journal:  Neurochem Int       Date:  2018-11-16       Impact factor: 3.921

8.  The role of substance P in acupuncture signal transduction and effects.

Authors:  Yu Fan; Do-Hee Kim; Young Seob Gwak; Danbi Ahn; Yeonhee Ryu; Suchan Chang; Bong Hyo Lee; Kyle B Bills; Scott C Steffensen; Chae Ha Yang; Hee Young Kim
Journal:  Brain Behav Immun       Date:  2020-09-18       Impact factor: 7.217

9.  Mitigation of Oxidation in Therapeutic Antibody Formulations: a Biochemical Efficacy and Safety Evaluation of N-Acetyl-Tryptophan and L-Methionine.

Authors:  Michelle Z Dion; Danielle Leiske; Vikas K Sharma; Christina L Zuch de Zafra; Cleo M Salisbury
Journal:  Pharm Res       Date:  2018-10-02       Impact factor: 4.200

10.  HIV infection of macrophages is enhanced in the presence of increased expression of CD163 induced by substance P.

Authors:  Florin Tuluc; John Meshki; Sergei Spitsin; Steven D Douglas
Journal:  J Leukoc Biol       Date:  2014-02-27       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.